Physician profile
James Paulson
NPI 1033297221
$1,620.37
in general payments reported to CMS, 2019-2025
15 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $154 · 2021: $135 · 2022: $95.38 · 2023: $399 · 2024: $181 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $392.29 | 2020-2025 | Precision7, Total30 |
| Maculogix, INC. | $200.00 | 2019 | |
| Optovue, INC. | $181.97 | 2019 | |
| Coopervision INC. | $173.58 | 2020-2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $156.00 | 2023-2024 | Infuse, Miebo, Vyzulta |
| Topcon Healthcare, INC. | $104.47 | 2023 | |
| Sun Pharmaceutical Industries INC. | $97.96 | 2021 | |
| New World Medical,INC. | $91.89 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Carl Zeiss Meditec USA, INC. | $54.59 | 2025 | Cirrus Hd-Oct |
| Shire North American Group INC | $50.15 | 2019 | |
| Oyster Point Pharma, INC. | $44.66 | 2022-2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $21.00 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $16.51 | 2023 | Acuvue |
| Optos, INC. | $15.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Paulson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.